Abraxane Combination Improves Survival In Treatment-Naïve Metastatic Disease
Avastin Increases Overall Survival 3.7 Months
First-Line Bendamustine Doubles PFS In Non-Hodgkin and Mantle Cell Lymphoma
Phase III Trial of ThermoDox Fails to Meet Primary Endpoint
Neulasta Reduces Incidence Of Febrile Neutropenia
Tivozanib Does Not Improve OS Compared to Sorafenib
In Surgery vs Radiotherapy, Outcome Differences Equalize After 15 Years Follow-up
Genomic Test More Accurate In Predicting Metastasis Than PSA, Tumor Stage & Grade
Protein May Link Obesity To Cancer Aggressiveness
“Triple-Negative” Should Be Split Into Subtypes, Say Researchers
NCI CTEP Approved Trials For the Month of February
Avastin Combination Approved For Metastatic Colorectal Cancer
FDA Grants Priority Review To Two Drugs in NSCLC
Trending Stories
- Abdallah Abou Zahr, an oncologist whose cancer story resonated widely, dies of liposarcoma at 42
- Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched - Supportive cancer care is the smart investment our leaders in Washington can’t afford to ignore
- Fifth time’s a charm? Mikaela Naylon Give Kids a Chance Act is included in FY26 spending bill
- On Day 2 as director of NYU Perlmutter, Anirban Maitra talks about the advantages of running a matrix cancer center
- Letai: NCAB’s ad hoc working group plays major role in advising NCI on extramural research
The group replaced the NCI Board of Scientific Advisors
